CD8A and neoplasm: However, it has also been found that CCL2 blockade does not inhibit the recruitment of TAMs, but tilts the polarization of TAMs toward M1, showing a stronger anti-tumor phenotype, and activating CD8+ T cells in the tumor to destroy the tumor cell (152).